HSP90AA1 and myeloid sarcoma: Firstly, we observed a significant increase in HSP90 levels in MS patients as compared with the control group (median = 0.6455 ng/mL vs. 0.48 ng/mL) as well as HSP60 levels (median = 1752.07 ng/mL, vs. 1280.5 ng/mL).